| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5617906 | BAXTER HLTHCARE | Container for anaesthetic agent |
Apr, 2014
(10 years ago) | |
|
US5617906 (Pediatric) | BAXTER HLTHCARE | Container for anaesthetic agent |
Oct, 2014
(9 years ago) | |
Suprane is owned by Baxter Hlthcare.
Suprane contains Desflurane.
Suprane has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Suprane are:
- US5617906
- US5617906*PED
Suprane was authorised for market use on 18 September, 1992.
Suprane is available in liquid;inhalation dosage forms.
The generics of Suprane are possible to be released after 08 October, 2014.
Drugs and Companies using DESFLURANE ingredient
Market Authorisation Date: 18 September, 1992
Treatment: NA
Dosage: LIQUID;INHALATION
How can I launch a generic of SUPRANE before it's drug patent expiration?
More Information on Dosage
SUPRANE family patents
